Scenarios that move PTGX

Protagonist Therapeutics, Inc. - Common Stock

Scenarios that move PTGX: 1 analysis, 0 positive, 1 negative.

  1. · Spyre Therapeutics prices $350 million public stock offering — ▼ · impact -12 · confidence low · horizon quarters

All scenarios · Run a scenario · Pricing